TRY IBOTTLE+ RISK-FREE — SAVE $200 FOR A LIMITED TIME

Our Services

Web Design

Your content goes here. Edit or remove this text inline.

Logo Design

Your content goes here. Edit or remove this text inline.

Web Development

Your content goes here. Edit or remove this text inline.

VIEW ALL SERVICES

Shop Our Products

Hoodies

Your content goes here. Edit or remove this text inline.

T-Shirts

Your content goes here. Edit or remove this text inline.

Jeans

Your content goes here. Edit or remove this text inline.

BROWSE ALL OUR PRODUCTS

More of us

Customer Reviews

Your content goes here. Edit or remove this text inline.

Good Stuff We do!

Your content goes here. Edit or remove this text inline.

More From Us...

Your content goes here. Edit or remove this text inline.

EXPLORE CUSTOMERS STORIES

Discussion – 

0

Discussion – 

0

Effects of Alkaline-Reduced Drinking Water on Irritable Bowel Syndrome with Diarrhea: A Randomized Double-Blind, Placebo-Controlled Pilot Study


Hydrogen Water Studies

Irritable Bowel SyndromeDiarrhea

Effects of Alkaline-Reduced Drinking Water on Irritable Bowel Syndrome with Diarrhea: A Randomized Double-Blind, Placebo-Controlled Pilot Study

by Cheol Min Shin, Dong Ho Lee, Dong Woo Shin, Hyuk Yoon, Hyun Soo Kim, Nayoung Kim, Yoon Jin Choi, Young Soo Park

Abstract:

Objectives: The purpose of this study was to investigate whether the ingestion of alkaline-reduced water (ARW) is helpful in improving the symptoms of diarrhea-predominant irritable bowel syndrome (IBS). Methods: Twenty-seven patients (male, 25.9%; mean, 41.7 years old) with diarrhea-predominant IBS were randomly allocated to two groups. For eight weeks, the ARW group (n = 13) ingested at least 2 liters/day of ARW, while the control group (n = 14) ingested placebo water. IBS symptom scores (quality-of-life, abdominal pain/discomfort), stool form, and frequency were assessed before and after treatment via questionnaires. Results: Eight patients (61.5%) in the ARW group and six patients (42.9%) in the control group indicated that their symptoms had improved in more than four out of the eight weeks of treatment (p = 0.449). The IBS quality-of-life score significantly improved from 57.2 to 30.8 in the ARW group; this improvement was significantly greater than the slight improvement from 48.7 to 42.2 observed in the control group (p = 0.029). The abdominal pain score improved from 1.8 to 0.9 in the ARW group and from 1.8 to 1.1 in the control group, with no significant group difference (p = 0.232). Conclusions: Drinking ARW for eight weeks improves the quality of life in patients with diarrhea-predominant IBS.

Read more:

https://doi.org/10.1155/2018/9147914

Related Articles:

Sam Soliman

Research Scientist at iBottle

0 Comments

Submit a Comment

My cart
Your cart is empty.

Looks like you haven't made a choice yet.